Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge

About this episode

The episode discusses the impact of AI on drug design and the competitive landscape of obesity medications.

From designing drugs with a simple text prompt to running experiments guided by extended reality, a new wave of agentic AI is transforming the modern lab. Our editors discuss the latest autonomous systems accelerating biological discovery. In business deals, Gilead Sciences has acquired Tubulis in a transaction worth up to $5 billion, strengthening the buyer’s position in antibody–drug conjugates for cancer. Correspondingly, Eli Lilly and Biogen are each making billion-dollar-plus bets, acquiring Centessa, a sleep disorder drug developer, and Apellis, known for its work in immunology and rare diseases. Our episode rounds out by unpacking the dynamic obesity drug market, where intensifying competition from Novo Nordisk’s Wegovy pill is prompting Lilly to temper the 2026 sales outlook for its oral obesity drug, Foundayo. Join GEN editors Corinna Singleman, PhD, Fay Lin, PhD and Alex Philippidis for a discussion of the latest biotech and biopharma news.    Listed below are links to the GEN stories referenced in this episode of Touching Base :    Can AI Agents Automate Scientific Discovery? By Fay Lin, PhD, GEN Edge , April 1, 2026 Gilead to Acquire Tubulis for Up…

People in this episode

Hosts: Corinna Singleman, Fay Lin, Alex Philippidis

Topics covered

• AI in drug design
• biotech news
• biopharma competition
• obesity drugs
• business acquisitions
• scientific discovery

Keywords

• AI
• drug design
• biotech
• obesity drugs
• acquisitions
• biopharma
• Gilead
• Lilly
• Novo Nordisk

Mentioned in this episode

Organizations: Gilead Sciences, Tubulis, Eli Lilly, Biogen, Centessa, Apellis

Products: Wegovy, Foundayo

More episodes of Touching Base

• A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News · June 4, 2026 · 37 min
• AI Scientists, Stock Tumble, Patent Lawsuit, and New Partnerships · May 22, 2026 · 32 min
• Remembering J. Craig Venter, PhD · May 7, 2026 · 44 min
• AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains · April 23, 2026 · 33 min
• Agentic AI, Virtual Cell, LNP Vaccine Boosters, Engineered Organs, and Mergers · March 26, 2026 · 40 min
• Bacteria 4D Simulation, Safer Large Gene Insertion, uniQure Roller Coaster · March 13, 2026 · 41 min